Global Biotech Partnering Terms and Agreements Analysis Report 2010-2017: Deal Trends, Players and Financials - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Biotech Partnering Terms and Agreements 2010-2017: Deal trends, players and financials" report to their offering.

Global Biotech Partnering Terms and Agreements 2010 to 2017 report provides a detailed understanding and analysis of how and why companies enter Biotech partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

The report takes the reader through a comprehensive review Biotech deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Biotech partnering deals.

The report presents financial deal term values for Biotech deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

One of the key highlights of the report is that over 7,000 online deal records of actual Biotech deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

Report scope:

  • Trends in Biotech dealmaking in the biopharma industry since 2010
  • Analysis of Biotech deal structure
  • Access to headline, upfront, milestone and royalty data
  • Case studies of real-life Biotech deals
  • Access to Biotech contract documents
  • Leading Biotech deals by value since 2010
  • Most active Biotech dealmakers since 2010

Deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Biotech dealmaking

Chapter 3 - Leading Biotech deals

Chapter 4 - Most active Biotech dealmakers

Chapter 5 - Biotech contracts dealmaking directory

Chapter 6 - Biotech dealmaking by technology type

Chapter 7 - Partnering resource center

For more information about this report visit http://www.researchandmarkets.com/research/46m77q/global_biotech

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology